XLV vs. GERM
XLV (State Street Health Care Select Sector SPDR ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - XLV tracks the Health Care Select Sector Index while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, XLV returned 12.89% vs 0.00% for GERM. XLV charges 0.08%/yr vs 0.68%/yr for GERM.
Performance
XLV vs. GERM - Performance Comparison
Loading charts...
Returns By Period
XLV
- 1D
- 0.79%
- 1M
- 1.95%
- YTD
- -4.29%
- 6M
- -4.06%
- 1Y
- 12.89%
- 3Y*
- 5.98%
- 5Y*
- 5.55%
- 10Y*
- 9.20%
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XLV vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
XLV State Street Health Care Select Sector SPDR ETF | -4.29% | 14.50% | -9.90% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
XLV vs. GERM - Sectors Allocation Comparison
Sectors
XLV
GERM
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XLV
GERM
Basic Materials
XLV
-
GERM
-
Communication Services
XLV
-
GERM
-
Consumer Cyclical
XLV
-
GERM
-
Consumer Defensive
XLV
-
GERM
-
Energy
XLV
-
GERM
-
Financial Services
XLV
-
GERM
Industrials
XLV
-
GERM
-
Real Estate
XLV
-
GERM
-
Technology
XLV
-
GERM
-
Utilities
XLV
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLV vs. GERM — Risk / Return Rank
XLV
GERM
XLV vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR ETF (XLV) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XLV | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.16 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.24 | — | — |
| Martin ratioReturn relative to average drawdown | 2.99 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XLV | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.88 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.38 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.56 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | — | — |
Drawdowns
XLV vs. GERM - Drawdown Comparison
The maximum XLV drawdown since its inception was -39.17%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for XLV and GERM.
Loading charts...
Drawdown Indicators
| XLV | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.17% | 0.00% | -39.17% |
Max Drawdown (1Y)Largest decline over 1 year | -10.47% | 0.00% | -10.47% |
Max Drawdown (3Y)Largest decline over 3 years | -17.11% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -17.11% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -28.40% | — | — |
Current DrawdownCurrent decline from peak | -7.52% | 0.00% | -7.52% |
Average DrawdownAverage peak-to-trough decline | -7.12% | 0.00% | -7.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.32% | 0.00% | +4.32% |
Volatility
XLV vs. GERM - Volatility Comparison
State Street Health Care Select Sector SPDR ETF (XLV) has a higher volatility of 4.10% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that XLV's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XLV | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.10% | 0.00% | +4.10% |
Volatility (6M)Calculated over the trailing 6-month period | 10.24% | 0.00% | +10.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.67% | 0.00% | +14.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.69% | 0.00% | +14.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.55% | 0.00% | +16.55% |
XLV vs. GERM - Expense Ratio Comparison
XLV has a 0.08% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
XLV vs. GERM - Dividend Comparison
XLV's dividend yield for the trailing twelve months is around 1.70%, while GERM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLV State Street Health Care Select Sector SPDR ETF | 1.70% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
XLV has higher volatility (4.10%) compared to GERM (0.00%). In terms of maximum drawdown, XLV dropped -39.17% vs GERM's 0.00%.
On 1-year performance, XLV leads with 12.89% vs 0.00% for GERM. On fees, XLV is cheaper at 0.08% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, XLV has performed better with a 12.89% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.68% for GERM.
XLV has the higher dividend yield at 1.70%, compared with 0.00% for GERM.
XLV tracks Health Care Select Sector Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: State Street and Amplify. Their fees differ too: 0.08% for XLV and 0.68% for GERM.
Find the right allocation for XLV and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer